Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: AK2004 who wrote (528312)	1/23/2004 2:08:51 PM
From: Neocon	Read Replies (1) \| Respond to of 769667

Why would anyone sell below cost for any length of time, except to kill off a competitor, which is inapplicable to this situation? A brief period to promote the product, maybe, otherwise, there would always be a profit. The government is just another bulk buyer, in the case you mention. The drug companies themselves can front- end development costs, and refuse to sell for less. The reason they don't is because it is not yet necessary. Check on survival rates for various serious illnesses and medical procedures, for example. Check on the efficacy of care addressing chronic diseases (for example, the management of asthma or diabetes). Check on the link between infant mortality and the adherence to a disciplined prenatal regimen, including regular doctors visits. Check on the trend of earlier and more accurate diagnosis. There are all kinds of data that are useful in evaluating the increasing efficacy of medical treatment. If we are getting a bigger bang for the buck, what is there to complain about?